Warning: Undefined array key "file" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Warning: Undefined array key "title" in /home/www/wwwroot/HTML/www.exportstart.com/wp-content/themes/1198/header.php on line 7

Vorinostat CAS 149647-78-9

High Quality Antineoplastic Drugs Chemical Powder Vorinostat CAS 149647-78-9

 

  • Navê hilberê:

    Vorinostat CAS 149647-78-9

  • Sinif:

    Pharmaceutical grade/Cosmetic grade

  • Taybetmendî:

    toza spî

  • Bixçe:

    25 kg / tembûr

  • MOQ:

    1 kilo

  • Embarkirinî:Cihê Dry Cool
  • Jiyana rafê:2 sal


Details

Tags

Danasîna hilberê

Vorinostat is a potent HDAC inhibitor with significant applications in cancer treatment, regulating gene expression, and potentially antiviral activities.

  1. HDAC Inhibition: Vorinostat functions by specifically binding to and inhibiting HDAC, including HDAC1, HDAC2, HDAC3 (Class I), and HDAC6 (Class II), thereby altering the acetylation status of histones and other proteins.
  2. Gene Expression Regulation: By inhibiting HDAC activity, Vorinostat helps to restore normal gene expression patterns, which are often disrupted in cancer cells. This leads to cell cycle arrest and apoptosis (programmed cell death) in cancer cells.
  3. Antiviral Activity: Studies have also shown that Vorinostat has the potential to reactivate latent HIV virus in patients, although further research is needed to fully understand and exploit this antiviral property in clinical settings.

 

 

Bikaranînî
  1. Anticancer Drug: Vorinostat is primarily utilized as an anticancer agent, particularly in the treatment of cutaneous T-cell lymphoma (CTCL), a type of non-Hodgkin's lymphoma that has worsened, persisted, or recurred after two systemic therapies.
  2. FDA Approval: It was approved by the U.S. Food and Drug Administration (FDA) in October 2006 for the treatment of skin cancer, marking it as the first FDA-approved drug for metastatic CTCL when other therapies have failed, the disease has worsened, or has returned.
  3. Combination Therapy: Vorinostat can also be used in combination with other antitumor drugs to enhance their synergistic effects.

 

Avantajên

Me gelek kargehên kalîteya bilind bi hevkariyek kûr heye, ku dikarin ji we re hilberên kalîteya bilind û bihayên reqabetê peyda bikin. Û em dikarin ji bo kirînên mezin erzanan jî bidin. Û em bi gelek pargîdaniyên barkêş ên profesyonel re hevkariyê dikin, dikarin hilberan bi ewlehî û bi aramî radestî destên we bikin. Dema radestkirinê piştî pejirandina dravdanê 3-20 rojan e.

 

Specification

 

Shipping û dayina


 

FAQ

1. Ma hûn kargehek an pargîdaniyek bazirganî ne?
Em pargîdaniyek in ku pîşesazî û bazirganiyê entegre dike, karûbarê yek-stop peyda dike. OEM dikare were pejirandin.

2. Ma hûn nimûne pêşkêş dikin? Ew belaş an zêde ye?
Nimûneyên belaş. Pêdivî ye ku heqê barkirina nimûneyê ji hêla we ve were dayîn.

3. Hûn belgeyên ku bi kontrola kalîteyê ve girêdayî ne?
Sertîfîkaya ISO 9001: 2008 ji bo misogerkirina kalîteyê.

4. Divê ez çi peyda bikim da ku jêderkek bistînim?
Ji kerema xwe celebê hilberê ku hûn hewce ne, hêjmara fermanê, navnîşan û hewcedariyên taybetî me agahdar bikin. Dê di wextê de ji bo referansa we veqetandin were çêkirin.

5. Hûn rêbazek dravdanê çawa tercîh dikin? Mercên çawa têne qebûl kirin?
Mercên Radestkirina Pejirandî: FOB, CFR, CIF, EXW;
Pereyê Tezmînata Qebûlkirî:USD;
Accepted Payment Type: T/T,Western Union; Paypal,BTC
Zimanê axaftinê: Îngilîzî.

 

Heke hûn bi hilberên me re eleqedar in, hûn dikarin hilbijêrin ku agahdariya xwe li vir bihêlin, û em ê di demek nêzîk de bi we re têkilî daynin.


Peyama xwe li vir binivîse û ji me re bişîne